Detalhe da pesquisa
1.
Persistence to Basal Insulin: Association With Health Outcomes in a Population With Type 2 Diabetes.
Clin Diabetes
; 42(2): 257-265, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38694243
2.
Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment.
J Biomed Inform
; 101: 103355, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838211
3.
Evaluation of a drug-drug interaction: fax alert intervention program.
BMC Med Inform Decis Mak
; 13: 32, 2013 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497373
4.
Assessing patients' information needs regarding drug-drug interactions.
J Am Pharm Assoc (2003)
; 53(1): 39-45, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23636154
5.
Assessment tool for pharmacy drug-drug interaction software.
J Am Pharm Assoc (2003)
; 51(3): 418-24, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21555296
6.
Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
Am Health Drug Benefits
; 14(3): 101-109, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261713
7.
Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
J Manag Care Spec Pharm
; 27(8): 971-981, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337985
8.
Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
Explor Res Clin Soc Pharm
; 32021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35434697
9.
Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.
Curr Med Res Opin
; 37(9): 1581-1588, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039232
10.
Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
Res Social Adm Pharm
; 17(8): 1469-1477, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272859
11.
Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.
J Am Geriatr Soc
; 67(3): 581-587, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674080
12.
Drug-drug interaction software quality assurance: Lessons learned.
J Am Pharm Assoc (2003)
; 51(5): 570-2, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21896453
13.
Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up.
J Manag Care Spec Pharm
; 22(6): 618-25, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27231790
14.
Recommendations for selecting drug-drug interactions for clinical decision support.
Am J Health Syst Pharm
; 73(8): 576-85, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27045070
15.
Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
J Am Med Inform Assoc
; 22(6): 1243-50, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25829460
16.
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.
Drug Saf
; 38(2): 197-206, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556085
17.
The good, the bad, and the different: a primer on aspects of heterogeneity of treatment effects.
J Manag Care Spec Pharm
; 20(6): 555-63, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24856593
18.
Evaluation of an educational program on deciphering heterogeneity for medical coverage decisions.
J Manag Care Spec Pharm
; 20(6): 566-73, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24856595
19.
Prescriber perceptions of a near real-time fax alert program for potential drug-drug interactions.
J Manag Care Spec Pharm
; 20(5): 494-500a, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24761821
20.
Health care decision makers' use of comparative effectiveness research: report from a series of focus groups.
J Manag Care Pharm
; 19(9): 745-54, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156643